NCT03748069 Influenza Associated Aspergillosis In-depth Investigation
| NCT ID | NCT03748069 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitaire Ziekenhuizen KU Leuven |
| Condition | Influenza With Pneumonia |
| Study Type | OBSERVATIONAL |
| Enrollment | 45 participants |
| Start Date | 2019-01-18 |
| Primary Completion | 2027-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45 participants in total. It began in 2019-01-18 with a primary completion date of 2027-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This trial is aimed to study the immunological and pathological characteristics of influenza versus non-influenza severe community-acquired pneumonia patients in ICU.
Eligibility Criteria
Inclusion Criteria: * All patients older than 18 years, admitted to ICU with respiratory distress with microbiologically confirmed diagnosis of influenza (for inclusion in the influenza group) * All patients older than 18 years, admitted to ICU for respiratory distress due to community- acquired pneumonia , with a microbiologically confirmed absence of influenza (for inclusion in the control group) Exclusion Criteria: * Age \< 18 years old * Pregnant women * No informed consent
Contact & Investigator
Joost Wauters, PhD
PRINCIPAL INVESTIGATOR
UZ Leuven
Frequently Asked Questions
Who can join the NCT03748069 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Influenza With Pneumonia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03748069 currently recruiting?
Yes, NCT03748069 is actively recruiting participants. Contact the research team at joost.wauters@uzleuven.be for enrollment information.
Where is the NCT03748069 trial being conducted?
This trial is being conducted at Leuven, Belgium.
Who is sponsoring the NCT03748069 clinical trial?
NCT03748069 is sponsored by Universitaire Ziekenhuizen KU Leuven. The principal investigator is Joost Wauters, PhD at UZ Leuven. The trial plans to enroll 45 participants.